Evidence map›Paper›PMID 41547916›Full record

ArticleCommunications biology2026

HBP1 enhances progesterone receptor activity and IGFBP1 expression driving endometrial decidualization.

Yuying Guo, Wencai Tian, Changjun Nie, Jiwei Huang, Huiliu Fan, Zhengqin Chen, Zhong Lin, Aiping Qin, Pinxiu Huang

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuying Guo *Reproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.ORCID http://orcid.org/0000-0002-9227-2630
Wencai Tian *Reproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Changjun NieCenter of Reproductive Medicine, Liuzhou Hospital of Guangzhou Women and Children's Medical Center, Liuzhou, Guangxi, China.
Jiwei HuangCenter of Reproductive Medicine, Liuzhou Hospital of Guangzhou Women and Children's Medical Center, Liuzhou, Guangxi, China.
Huiliu FanCenter of Reproductive Medicine, Liuzhou Hospital of Guangzhou Women and Children's Medical Center, Liuzhou, Guangxi, China.
Zhengqin ChenDepartment of Reproductive Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, China.
Zhong LinReproductive Medicine Department, The Reproductive Hospital of Guangxi Zhuang Autonomous Region, Nanning, China. uters11uters@126.com.ORCID http://orcid.org/0000-0002-4661-306X
Aiping QinReproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. qinaiping@gxmu.edu.cn.ORCID http://orcid.org/0000-0002-0185-7204
Pinxiu HuangDepartment of Reproductive Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, China. huangpinxiu@163.com.ORCID http://orcid.org/0000-0002-9011-4970

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82160296National Natural Science Foundation of China (National Science Foundation of China) 82460309
6 · The paper itself

Abstract

Decidualization of human endometrial stromal cells (HESCs) is one of the critical steps in the establishment of human pregnancy. Nevertheless, little is known about the molecular mechanisms underlying human decidualization. In this study, we identified high-mobility group box transcription factor 1 (HBP1) as a key player in the decidualization of HESCs. Knockdown of HBP1 expression significantly reduced the mRNA and protein expression levels of the decidualization markers insulin-like growth factor-binding protein 1 (IGFBP1) and forkhead box O1 (FOXO1). Although progesterone receptor (PGR) expression did not significantly change, the expression levels of PGR-regulated target molecules decreased. Furthermore, ChIP-Seq and RNA-Seq analyses revealed that HBP1 directly transcriptionally regulates IGFBP1 expression. Additionally, overexpression of HBP1 promoted the enrichment of histone H3K4me3 at the promoter regions of PGR and its target molecules FK506 binding protein 5 (FKBP5), Fos-related antigen 2 (FRA-2/FOSL2), and FK506-binding protein 4 (FKBP4), which indicated that HBP1 enhances PGR transcriptional activity. Clinical specimen analysis further confirmed that the expression of HBP1 and PGR target molecules was significantly downregulated in the endometria of patients with recurrent implantation failure. In conclusion, this study provides evidence that HBP1 plays an important regulatory role in embryo implantation.

Indexed as

DeciduaEndometriumInsulin-Like Growth Factor Binding Protein 1Receptors, ProgesteroneRepressor ProteinsEmbryo ImplantationFemaleGene Expression RegulationHigh Mobility Group ProteinsHumansPregnancyStromal CellsHBP1 protein, humanHigh Mobility Group ProteinsIGFBP1 protein, humanInsulin-Like Growth Factor Binding Protein 1Receptors, ProgesteroneRepressor Proteins

Identifiers

PMID41547916
PMCPMC12921247

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.